Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Aflibercept Versus Ranibizumab in Management of Diabetic Macular Edema

NCT04087746 is registered in ClinicalTrials.gov with Minia University as lead sponsor.

NCT NCT04087746
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04087746 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Aflibercept Versus Ranibizumab in Management of Diabetic Macular Edema
Lead sponsor
Minia University
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2017
Completion date
June 30, 2019
Enrollment
400 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema